Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways

Enhancing lobaplatin sensitivity in lung adenocarcinoma through inhibiting LDHA-targeted metabolic pathways

Saved in:

Bibliographic Details
Main Authors:	Siyu Yuan, Wenjie Ou, Xuguang Mi, Junjie Hou
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649076/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma
by: Tung-Wei Hsu, et al.
Published: (2025-02-01)

Long non-coding RNA CAR10 promotes angiogenesis of lung adenocarcinoma by mediating nuclear LDHA to epigenetically regulate VEGFA/C
by: Xiaolu Ge, et al.
Published: (2025-01-01)

Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury
by: Yang Feng, et al.
Published: (2024-05-01)

Flipping the Target: Evaluating Natural LDHA Inhibitors for Selective LDHB Modulation
by: Amanda El Khoury, et al.
Published: (2025-07-01)

Impact of intraperitoneal lavage with lobaplatin on survival in patients undergoing hepatectomy for ruptured hepatocellular carcinoma
by: Xing Lv, et al.
Published: (2025-03-01)

Curcumin Antagonizes Glucose Fluctuation-Induced Renal Injury by Inhibiting Aerobic Glycolysis via the miR-489/LDHA Pathway
by: Xiaomei Fu, et al.
Published: (2021-01-01)

Author Correction: Tetrahydrobiopterin metabolism attenuates ROS generation and radiosensitivity through LDHA S-nitrosylation: novel insight into radiogenic lung injury
by: Yang Feng, et al.
Published: (2025-07-01)

Uric acid mediates kidney tubular inflammation through the LDHA/ROS/NLRP3 pathway
by: Jun Ouyang, et al.
Published: (2024-12-01)

Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
by: Hao Su, et al.
Published: (2025-06-01)

Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC
by: Hao Wen, et al.
Published: (2025-07-01)

Deep learning radiopathomics predicts targeted therapy sensitivity in EGFR-mutant lung adenocarcinoma
by: Taotao Yang, et al.
Published: (2025-04-01)

Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway
by: Jingyuan Zhang, et al.
Published: (2025-01-01)

Correction: Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway
by: Jingyuan Zhang, et al.
Published: (2025-02-01)

NCAPD3 contributes to lung cancer progression through modulated lactate-induced histone lactylation and MEK/ERK/LDHA axis
by: Zhibo Chang
Published: (2025-05-01)

Ticagrelor inhibits the growth of lung adenocarcinoma by downregulating SYK expression and modulating the PI3K/AKT pathway
by: Yuanhong Song, et al.
Published: (2025-05-01)

GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma
by: Dong-Gun Kim, et al.
Published: (2024-12-01)

Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning.
by: Patrick Y Sips, et al.
Published: (2018-01-01)

Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach
by: Bader Alshehri
Published: (2025-08-01)

TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer
by: HU Wei, REN Xiaomeng, WANG Yang, ZHAO Peiqing, CAO Kai
Published: (2025-04-01)

Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
by: Jingyang Li, et al.
Published: (2025-02-01)

Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis
by: Xingzhen Cheng, et al.
Published: (2022-01-01)

The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma
by: Xianhui Ruan, et al.
Published: (2025-07-01)

Identification of Shared Pathways and Molecules Between Type 2 Diabetes and Lung Adenocarcinoma and the Impact of High Glucose Environment on Lung Adenocarcinoma
by: Mengsi Yang, et al.
Published: (2025-01-01)

Targeting FCRLA to induce necrosis in lung adenocarcinoma: a novel strategy for prognosis and therapy via MPT-Driven pathways
by: Xiaoli Sun, et al.
Published: (2025-08-01)

Targeting NLRC4 for potential therapeutic strategies in lung adenocarcinoma
by: Xue Xu, et al.
Published: (2025-06-01)

Identification and validation of LDHA and SLC16A1 for predicting prognosis and diagnosis in lower-grade glioma
by: Jingyi Huang, et al.
Published: (2025-08-01)

LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation
by: Xiaoyong Wei, et al.
Published: (2025-05-01)

Corynoxine suppresses lung adenocarcinoma proliferation and metastasis via inhibiting PI3K/AKT pathway and suppressing Cyclooxygenase-2 expression
by: Liping Chen, et al.
Published: (2024-11-01)

Pan-cancer analysis of CHRDL1 expression and its mechanistic role in inhibiting EMT via the TGF-β pathway in lung adenocarcinoma
by: Honghong Dong, et al.
Published: (2025-03-01)

Inhibition of JNK/STAT3/NF-KB pathway-mediated migration and clonal formation of lung adenocarcinoma A549 cells by daphnetin
by: Zhe Lv, et al.
Published: (2024-12-01)

Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation
by: Jiahui Dong, et al.
Published: (2025-07-01)

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway
by: Jiali Wang, et al.
Published: (2024-12-01)

Follicular fluid-derived extracellular vesicles miR-34a-5p regulates granulosa cell glycolysis in polycystic ovary syndrome by targeting LDHA
by: Xueying Cui, et al.
Published: (2024-11-01)

Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma
by: Yu Chen, et al.
Published: (2024-07-01)

The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma
by: Chuan Xu, et al.
Published: (2025-03-01)

Ergotamine Targets KIF5A to Facilitate Anoikis in Lung Adenocarcinoma
by: Bin Bao, et al.
Published: (2024-11-01)

Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo
by: Lingxue Tang, et al.
Published: (2024-11-01)

Histones Methyltransferase NSD3 Inhibits Lung Adenocarcinoma Glycolysis Through Interacting with PPP1CB to Decrease STAT3 Signaling Pathway
by: Yanling Zhou, et al.
Published: (2024-10-01)

Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma
by: Dawei Sun, et al.
Published: (2025-04-01)

MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
by: Xiaofei Wang, et al.
Published: (2022-01-01)